Buscador de publicaciones<< Volver
Novella S, Martínez AC, Pagán RM, Hernández M, García-Sacristán A, González-Pinto A, González-Santos JM, Benedito S
Plasma levels and vascular effects of vasopressin in patients undergoing coronary artery bypass grafting.
Eur J Cardiothorac Surg. 2007 Jul;32(1):69-76, PMID: 17507236
Recent studies have suggested that endogenous vasopressin (AVP) acts as a spasmogen during coronary artery bypass grafting (CABG). Given that AVP could induce vasospasm in the grafted vessel, we assessed the release of this peptide during and after CABG, and explored ways of counteracting its contractile effect on the internal mammary artery (IMA).
CARDIAC & CARDIOVASCULAR SYSTEMS
Una iniciativa de
